Reply to "DAA and HBV/HCV co-infection: Glimmer of light and a few shades of grey"

J Hepatol. 2020 Aug;73(2):462. doi: 10.1016/j.jhep.2020.03.041. Epub 2020 Apr 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • Coinfection* / drug therapy
  • Hepatitis B virus
  • Hepatitis B* / complications
  • Hepatitis B* / drug therapy
  • Hepatitis B, Chronic* / drug therapy
  • Hepatitis C, Chronic* / complications
  • Hepatitis C, Chronic* / drug therapy
  • Humans

Substances

  • Antiviral Agents